Kaden Biotech Limited
12598519
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/05/2025
total exemption full
Next accounts due
28/02/2027
Confirmation statement
Last: 11/05/2026
Due 25/05/2027
Industry
Officers
director · Since 12/05/2020
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 55
Also on 2 other boards
Persons with Significant Control
Mr Jason Edward Borrows
British · England · Age 55
31a, Thayer Street, London, W1U 2QS
Notified 12/05/2020
CompanyRankvs 1456+ SIC 64205 peers52
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2025
Net Worth
£188k
Balance sheet strength
Cash
£14k
Cash in the bank
Net Current Assets
£343k
Working capital
Current Assets
£24k
Current Liabilities
£367k
Debtors
£10k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.07 | -£7k |
| 2024 | 0.13 | +£38k |
| 2023 | 0.02 | — |
Derived from filed accounts. Not audited figures.